Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC)

CUSIP: 68622P109

Q2 2025 13F Holders as of 30 Jun 2025

Security type / class
Equity / Common Stock, $0.0001 par value per share
Total 13F shares
93,349,298
Total 13F value
$947,499,065
Holder snapshot 6 visible 7 signals
Share change
+14,060,740
Put/Call ratio
0.98%
SEC-reported price per share
$10.15
Number of holders
140
Value change
+$169,716,912
Number of buys
75
Open additional details 1 more signal available
Number of sells
85
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
105,956,500

Security key

68622P109

Report period

Q2 2025

Institutions

140

Top holders

10

ORIC full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Previous quarter: Q1 2025 Oric Pharmaceuticals, Inc. SEC filings Oric Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ORIC - Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Nextech Crossover I GP S....
Disclosed value leader
Nextech Crossover I GP S....
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G 13F 3/4/5 Lead comparable stake: 8.4% 13D/G row: Nextech Crossover I GP S.a r.l. Showing 1-6 of 15 holder rows.

Quick read

Nextech Crossover I GP S.a r.l. leads the comparable SEC ownership view at 8.4%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Nextech Crossover I GP S.a r.l.'s linked filing trail.
Comparable ownership Top 5
Nextech Crossover I GP S.a r.l. 8.4%
FMR LLC 3.5%
Frazier Life Sciences Public Fund... 2%
VIKING GLOBAL INVESTORS LP 6.2%
BlackRock, Inc. 5.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Nextech Crossover I GP S.a r.l.
13D/G
13D/G
8.4%
$78,072,743
7,162,637 shares
 $0 30 Jun 2025
FMR LLC
13D/G 13F
Company
13D/G 13F
3.5%
$13,967,797
2,467,809 shares
 $0 31 Dec 2024
Frazier Life Sciences Public Fund, L.P.
13D/G
James N. Topper
13D/G
2%
$7,981,692
1,410,193 shares
 $0 31 Mar 2025
VIKING GLOBAL INVESTORS LP
13F
Company
13F
6.2%
$36,675,666
6,572,700 shares
 — 31 Mar 2025
BlackRock, Inc.
13F
Company
13F
5.1%
$30,327,787
5,435,087 shares
 — 31 Mar 2025
PFIZER INC
3/4/5 13F
10%+ Owner · Company
3/4/5 13F
5.1%
from 13F
$46,160,752
5,376,344 shares
 — 23 Dec 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
140
Shares
93,349,298
Rows available
140
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
142
Q2 2025 holders
140
Holder diff
-2
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .